Dáil debates

Thursday, 25 February 2010

Adjournment Debate

Thalidomide Survivors.

4:00 pm

Photo of Chris AndrewsChris Andrews (Dublin South East, Fianna Fail)
Link to this: Individually | In context

I am pleased to have an opportunity to speak on this matter. Last Tuesday I met with members of the Irish Thalidomide Association who were in Leinster House to brief the Joint Committee on Health and Children on their situation. Their story is one of the most difficult and tragic I have come across, and is all the more upsetting because it could have been prevented. We can get bogged down in this House with legalities, politics, reports and so on and tend to forget about the individual stories. At the meeting Ms Maggie Woods gave a harrowing account of her life story which was upsetting to hear. It put the issue in context.

There are 32 acknowledged thalidomide survivors in the State, the children of women who unwittingly took the prescribed morning sickness medication with no realisation of the hugely damaging effect it would have on their unborn children. This drug was marketed between 1958 and 1961 and was withdrawn from use after it was linked to birth deformities. Thalidomide causes severe foetal damage by preventing the growth of new blood vessels at critical periods in the baby's development. The most obvious effects are absent or foreshortened limbs but children's vision and hearing were also affected while others sustained damage to internal organs. Many babies did not survive the pregnancy and many more died in infancy.

The 32 survivors are brave people who have managed to live extraordinary lives. They are remarkably well adjusted despite the difficulties they have encountered in their lives. They have managed to overcome those difficulties without any of the sense of bitterness and anger one might expect. They are well adjusted and surprisingly so given their experiences.

A lump sum was paid decades ago to the parents of survivors. However, the amount was small and it was not believed thalidomide victims would live long. Special assistance may be required to allow these survivors to continue to live as independently as possible. There is an onus on the State to provide monetary compensation to ensure the needs of these people are met.

Earlier last month the Northern Ireland Minister for Health, Mr. McGimpsey, announced a £1.1 million compensation package for survivors in Northern Ireland of thalidomide, of which there are 18. This followed on from the Britain's announcement of a compensation fund of £20 million for its 466 thalidomide survivors. I believe the Government has a responsibility to provide for our survivors.

Following two years of campaigning and almost 50 years of distress there has been no progress in regard to the review of the 1975 thalidomide agreement called for by the ITA. On Tuesday, the Oireachtas Joint Committee on Health and Children resolved to contact the Minister to request that they be included in the State claims agency report. The ITA is requesting an acknowledgment of the wrong done - it was wrong for this drug to be licensed by the State - an apology for survivors and the families of those who did not survive, and disclosure of documents. The Department of Health and Children has refused to grant voluntary disclosure of documents in all Departments pertaining to this tragedy, despite the passing of 50 years. The ITA is also requesting a fair and equitable compensation package, including a health care package that properly addresses the unique needs of this group to ensure they can maintain the level of deteriorating health they continue to experience and where possible to lead independent lives.

I ask that fairness and justice be applied to this particular group and that this matter be given full attention.

Photo of Áine BradyÁine Brady (Kildare North, Fianna Fail)
Link to this: Individually | In context

I am pleased to have this opportunity to outline the position in relation to the matter raised by the Deputy. The Minister and Department officials met with the Irish Thalidomide Association on a number of occasions at which the ITA sought a review of the payments by the Irish Government to the survivors of thalidomide.

The Minister considered the detailed proposals made by the ITA, met again with the association in March 2009 and undertook to consider its claim further. In May 2009, the Department asked the State claims agency to examine the association's claims and assess its requests in the context of Irish and International provisions for survivors of thalidomide and in the context of Irish case law and precedent and to advise the Minister accordingly. The State claims agency met with representatives of the association on 25 June last year and listened carefully to its position. The agency has expressed its willingness to meet again with the groups representing survivors of thalidomide, following which it will report to the Minister. Any proposal arising out of this process will need to be considered by Government.

The thalidomide product sold in Ireland was manufactured by Chemie Grunenthal - a German company. An offer of compensation made in 1970 by the German manufacturers of thalidomide applied to Irish children. The German compensation, paid through a statutory foundation set up for the purpose, was in the form of a lump sum and a monthly allowance for life. The foundation is funded by a covenant from the German drugs manufacturer. The Irish Government decided in 1974 to augment the compensation provided by the German foundation. The decision was to provide a lump sum of four times the German amount and a monthly allowance for life, which was equivalent to the German allowance, to each Irish survivor of thalidomide. The lump sum paid by the Irish Government in 1975 ranged from €6,400 to €21,200.

There are currently 32 Irish survivors of thalidomide. The Irish allowance is paid by the Department of Health and Children. The total annual payment received by survivors including the German payment is currently up to €28,500 per annum. The majority of Irish survivors receive the maximum amount. The monthly allowance is tax-free and is not reckonable for State benefits. Each individual is automatically entitled to a medical card.

The Government accepts the concerns expressed by the Irish survivors of thalidomide regarding their continuing and increasing health needs as they get older. The Minister awaits receipt of the report of the State claims agency.